Enanta Pharmaceuticals (ENTA) Other Working Capital Changes (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted Other Working Capital Changes of -$533000.0 for Q1 2026, up 36.09% on a QoQ basis from -$834000.0 in Q4 2025, and down 124.68% year-over-year from $2.2 million in Q1 2025.
Enanta Pharmaceuticals (ENTA) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals' Other Working Capital Changes history runs 15 years deep, the most recent figure standing at -$533000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 124.68% year-over-year to -$533000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 million (down 190.51% YoY) and the FY2025 annual result came in at $29000.0, up 106.71% from the prior year.
- Other Working Capital Changes was -$533000.0 for Q1 2026 at Enanta Pharmaceuticals, up from -$834000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.5 million in Q4 2022 and bottomed at -$4.2 million in Q4 2025.
- A 5-year average of -$276235.3 and a median of -$1.6 million in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 17766.67% — and 2025, when it slumped 20950.0%.
- Enanta Pharmaceuticals' Other Working Capital Changes stood at -$40000.0 in 2022, then sank by 2457.5% to -$1.0 million in 2023, then surged by 100.39% to $4000.0 in 2024, then slumped by 20950.0% to -$834000.0 in 2025, then jumped by 36.09% to -$533000.0 in 2026.
- Business Quant data shows ENTA's Other Working Capital Changes at -$533000.0 in Q1 2026, -$834000.0 in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.47 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | -4.25 Mn |
| Dec 31, 2025 | -4.25 Mn |
| Dec 31, 2025 | -4.25 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | -1.73 Mn |
| Dec 31, 2024 | -1.73 Mn |
| Dec 31, 2024 | -1.73 Mn |
| Sep 30, 2024 | -2.85 Mn |
| Sep 30, 2024 | -2.85 Mn |